Biogen Reports First Quarter 2017 Revenues of $2.8 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
Biogen (BIIB) PT Raised to $280 at Stifel
April 25, 2017 11:18 AM EDTStifel analyst Thomas Shrader raised his price target on Biogen (NASDAQ: BIIB) to $280.00 (from $265.00) while maintaining a Hold rating following results this morning.
The analyst noted the results were positive for the companys goal to trim some of the fat from... More
Biogen (BIIB) Tops Q1 EPS by 20c
April 25, 2017 7:00 AM EDTBiogen (NASDAQ: BIIB) reported Q1 EPS of $5.20, $0.20 better than the analyst estimate of $5.00. Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.74 billion.
Total revenues of $2.8 billion, a 3% increase versus the prior year and an 8% increase excluding hemophilia... More